-
Drug for pancreatic cancer developed by college of pharmacy researchers
worldpharmanews
September 13, 2018
A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.
-
Quizartinib Receives Orphan Drug Designation from Japanese MHLW
americanpharmaceuticalreview
September 12, 2018
Daiichi Sankyo Company announced quizartinib, an investigational FLT3 inhibitor, has been granted Orphan Drug designation by the Japan Ministry of Health, Labour and Welfare (MHLW) for the treatment of FLT3-mutated acute myeloid leukemia (AML).
-
Human Trials Begin for DesignMedix Anti-Malarial Drug
americanpharmaceuticalreview
September 11, 2018
DesignMedix’s lead product, experimental anti-malaria medicine DM1157, has begun human clinical trials. DM1157, discovered at Portland State University (PSU) and developed by PSU spin-out DesignMedix, was designed to overcome the serious issue of growing
-
Study links widely-used drug azathioprine to skin cancers
worldpharmanews
September 11, 2018
A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development, in a research study carried out at the Unive
-
Improving drug safety in East Africa is aim of new project
europeanpharmaceuticalreview
September 05, 2018
A new project led by the Karolinska Institutet in Sweden aims to improve the standards of drug safety in East Africa.
-
Multiple sclerosis drug slows brain shrinkage
europeanpharmaceuticalreview
September 04, 2018
In a recent clinical study, ibudilast slowed brain shrinkage better than a placebo in the brains of patients with multiple sclerosis…
-
Blood pressure drug slows aortic dilatation in Marfan syndrome
europeanpharmaceuticalreview
August 31, 2018
“Our finding of reduced aortic dilatation with irbesartan, over and above standard medical therapy, suggests an important clinical effect that may prevent complications and ultimately delay or obviate the need for surgical intervention in patients with Ma
-
Hebrew University researchers develop a drug for acute leukemia
biospectrumasia
August 29, 2018
Researchers at the Hebrew University of Jerusalem said they have developed a new biological drug that had a 50 percent cure rate for lab mice with acute leukemia.
-
Breast Cancer Drug Promising in Phase 3 Trial
drugs
August 16, 2018
For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests.
-
FDA Approves First Cancer Drug through New Oncology Review Pilot
americanpharmaceuticalreview
July 24, 2018
The U.S. Food and Drug Administration (FDA) approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive,